Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Hypertensive Effect of Sacubitril/Valsartan in Resistant Hypertension: Randomized Clinical Trial - The HEVA Study

NCT04637152 is registered in ClinicalTrials.gov with Hospital Geral Roberto Santos as lead sponsor.

NCT NCT04637152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04637152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Hypertensive Effect of Sacubitril/Valsartan in Resistant Hypertension: Randomized Clinical Trial - The HEVA Study
Lead sponsor
Hospital Geral Roberto Santos
Phase
Phase 2
Overall status
Completed
Start date
November 11, 2020
Completion date
August 17, 2022
Enrollment
80 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, resistant hypertension